Page last updated: 2024-08-16

ono 1078 and fluticasone

ono 1078 has been researched along with fluticasone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, K; Fukunaga, K; Hakuno, H; Hasegawa, N; Kanazawa, M; Kudo, H; Matsuzaki, T; Nakamura, H; Shiomi, T; Suzuki, Y; Yamaguchi, K1
Fukushima, C; Kawano, T; Kohno, S; Kondo, Y; Machida, I; Matsuse, H; Obase, Y; Saeki, S; Tomari, S1
Hata, H; Hayashi, N; Hirose, M; Horiguchi, T; Kobayashi, K; Kondo, R; Miyazaki, J; Nasu, T; Ohira, D; Otake, Y; Shiga, M; Tachikawa, S1
Adachi, M; Hirose, T; Ohbayashi, H; Shibata, N1
Hounoki, H; Ishizawa, S; Ogawa, R; Shinoda, K; Sugiyama, E; Taki, H; Tobe, K1

Trials

3 trial(s) available for ono 1078 and fluticasone

ArticleYear
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.
    Pharmacogenetics, 2002, Volume: 12, Issue:7

    Topics: Administration, Inhalation; Adult; Albuterol; Analysis of Variance; Androstadienes; Anti-Asthmatic Agents; Asian People; Asthma; Beclomethasone; Chromones; Female; Fluticasone; Forced Expiratory Volume; Genetic Carrier Screening; Glutathione Transferase; Humans; Japan; Leukotriene Antagonists; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic

2002
Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Chromones; Eosinophils; Female; Fluticasone; Humans; Leukotriene Antagonists; Male; Patient Compliance; Peak Expiratory Flow Rate; Sputum

2007
Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.
    Pulmonary pharmacology & therapeutics, 2009, Volume: 22, Issue:6

    Topics: Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Bronchodilator Agents; Chromones; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Emotions; Environment; Eosinophils; Female; Fluticasone; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Sputum

2009

Other Studies

2 other study(ies) available for ono 1078 and fluticasone

ArticleYear
Effects of various anti-asthmatic agents on mite allergen-pulsed murine bone marrow-derived dendritic cells.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2005, Volume: 35, Issue:7

    Topics: Albuterol; Androstadienes; Animals; Anti-Asthmatic Agents; Antigens, Dermatophagoides; Asthma; Bone Marrow Cells; Bronchoconstriction; Bronchodilator Agents; Chromones; Dendritic Cells; Female; Fluticasone; Interleukin-10; Interleukin-12; Mice; Mice, Inbred BALB C; Respiratory System; Salmeterol Xinafoate; Th2 Cells

2005
Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid.
    Scandinavian journal of rheumatology, 2010, Volume: 39, Issue:4

    Topics: Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Chromones; Churg-Strauss Syndrome; Drug Therapy, Combination; Eosinophil Cationic Protein; Fluticasone; Humans; Interleukin-5; Leukotriene Antagonists; Receptors, Interleukin-2; Severity of Illness Index; Treatment Outcome

2010